Estimating brand drugs' payoff from pay-for-delay deals
Year of publication: |
2023
|
---|---|
Authors: | Saha, Atanu ; Xu, Yong |
Published in: |
Journal of industry, competition and trade : from theory to policy. - Dordrecht [u.a.] : Springer Science + Business Media B.V, ISSN 1573-7012, ZDB-ID 2035199-9. - Vol. 23.2023, 1/2, p. 81-99
|
Subject: | Antitrust | Branded drugs | Generic entry | Pay for delay | Reverse payment | Markenartikel | Brand | Generika | Generic drugs | Arzneimittel | Pharmaceuticals | Markenführung | Brand management | Markteintritt | Market entry |
-
Competition between generic and brand name drugs : new evidence from the U.S. pharmaceutical market
Cavaliere, Alberto, (2022)
-
Branded vs. generic drugs : the role of self-perceived seriousness of disease
Sestino, Andrea, (2022)
-
The competitive impact of branded generic medicine in a developing country
Álvarez, Roberto, (2019)
- More ...
-
The "generic competition paradox" revisited
Saha, Atanu, (2021)
-
A market signal-based alternative to buy-and-hold investing
Saha, Atanu, (2021)
-
シンポジウム グローバリゼーションと現代歴史学 シンポジウムへの経過 = Symposium:Globalization and Modern History
Imanishi, Hajime, (2015)
- More ...